Table 1.
Disproportionality two-by-two contingency matrix
| User posts with the suspected ADR | User posts without the ADR | |
|---|---|---|
| User posts mentioning adalimumab | A | B |
| All other posts | C | D |
ADR adverse drug reaction
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.